Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Immunitas Therapeutics
Nurix Therapeutics, Inc.
Arcus Biosciences, Inc.
Seagen Inc.
Zumutor Biologics Inc.
Celldex Therapeutics
Stanford University
CytomX Therapeutics
Celgene
City of Hope Medical Center
Eastern Cooperative Oncology Group
Sorrento Therapeutics, Inc.
Celgene
AbbVie
Novartis
Incyte Corporation
University of Wisconsin, Madison
Incyte Corporation
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center